![2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ff64a9ee-c0db-4eef-b783-5f515ba33ccc/joa312652-toc-0001-m.jpg?trick=1668076029805)
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library
![Advantages and Disadvantages of Novel Oral Anticoagulants (NOACs) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group Advantages and Disadvantages of Novel Oral Anticoagulants (NOACs) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group](https://pharmaceuticalintelligence.com/wp-content/uploads/2018/03/noacs-table-1.png?w=640)
Advantages and Disadvantages of Novel Oral Anticoagulants (NOACs) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
![Comparison of upper gastrointestinal bleeding risk in users of warfarin... | Download Scientific Diagram Comparison of upper gastrointestinal bleeding risk in users of warfarin... | Download Scientific Diagram](https://www.researchgate.net/publication/352502469/figure/fig3/AS:1035889866182657@1623986798191/Comparison-of-upper-gastrointestinal-bleeding-risk-in-users-of-warfarin-and-4-NOACs-with.png)
Comparison of upper gastrointestinal bleeding risk in users of warfarin... | Download Scientific Diagram
![Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation | Circulation: Cardiovascular Quality and Outcomes Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation | Circulation: Cardiovascular Quality and Outcomes](https://www.ahajournals.org/cms/asset/fd08ec63-40df-423e-a85d-9de34c427f4c/circoutcomes.120.007230.fig01.gif)
Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation | Circulation: Cardiovascular Quality and Outcomes
Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
![PDF] Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Semantic Scholar PDF] Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f6650714338788ce610c0f562e51869ceb57aaf9/1-Table1-1.png)
PDF] Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. | Semantic Scholar
![Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery - Spyropoulos - 2016 - Journal of Thrombosis and Haemostasis - Wiley Online Library Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery - Spyropoulos - 2016 - Journal of Thrombosis and Haemostasis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1c06616a-0fd4-4ba4-a152-26989a6f13e3/jth13305-tbl-0006-m.jpg)
Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery - Spyropoulos - 2016 - Journal of Thrombosis and Haemostasis - Wiley Online Library
![Safety of new oral anticoagulant drugs: a perspective - Juan Antonio Vílchez, Pilar Gallego, Gregory Y.H. Lip, 2014 Safety of new oral anticoagulant drugs: a perspective - Juan Antonio Vílchez, Pilar Gallego, Gregory Y.H. Lip, 2014](https://journals.sagepub.com/cms/10.1177/2042098613507945/asset/images/large/10.1177_2042098613507945-fig1.jpeg)
Safety of new oral anticoagulant drugs: a perspective - Juan Antonio Vílchez, Pilar Gallego, Gregory Y.H. Lip, 2014
![Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation - Heart Rhythm Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation - Heart Rhythm](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/289d112f-211d-4f18-865d-a6e55a8fe533/gr1.jpg)
Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation - Heart Rhythm
![Novel Oral Anticoagulants (NOACs) Roundtable: Hot Topics and Current Issues in association with Arrhythmia & Electrophysiology Review | AER Journal Novel Oral Anticoagulants (NOACs) Roundtable: Hot Topics and Current Issues in association with Arrhythmia & Electrophysiology Review | AER Journal](https://assets.radcliffecardiology.com/s3fs-public/article/2021-07/Table-2-NOACs-in-Renal-Dysfunction-Practical.png)
Novel Oral Anticoagulants (NOACs) Roundtable: Hot Topics and Current Issues in association with Arrhythmia & Electrophysiology Review | AER Journal
![Table 3 from Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management | Semantic Scholar Table 3 from Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1e476b80a5a9387563173876865b24ac2242dba9/5-Table3-1.png)
Table 3 from Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management | Semantic Scholar
![Frontiers | Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach Frontiers | Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach](https://www.frontiersin.org/files/Articles/442679/fcvm-06-00017-HTML/image_m/fcvm-06-00017-g005.jpg)
Frontiers | Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach
![Cancers | Free Full-Text | Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools | HTML Cancers | Free Full-Text | Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools | HTML](https://www.mdpi.com/cancers/cancers-12-00191/article_deploy/html/images/cancers-12-00191-g001.png)
Cancers | Free Full-Text | Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools | HTML
![Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association | Circulation Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/a595e0bc-f5ad-425c-8fc4-ebbfe0f5f037/e604fig02.jpeg)